44 results
424B5
NNVC
NanoViricides Inc
4 Aug 23
Prospectus supplement for primary offering
5:54pm
of bio-defense drugs through NIH funding, the review process by the FDA and the final government procurement contracting authority. While this may
424B5
gi6iq zgi
31 Jul 20
Prospectus supplement for primary offering
5:29pm
424B5
psu 6fwqxt
9 Jul 20
Prospectus supplement for primary offering
5:13pm
424B5
q3izfyxe3fr1iz2
8 Jul 20
Prospectus supplement for primary offering
9:57pm
424B5
5rkk iqm581ctm7
21 May 20
Prospectus supplement for primary offering
9:21pm
424B1
u2ur3 ajcl
23 Jan 20
Prospectus with pricing info
9:04pm
S-1
s4d0pw54
28 Sep 19
IPO registration
3:07am